Drugs / cyclosporin A
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02099747 Background | Jul 2015 → Dec 2020 | aplastic anemia | European Society for Blood and Marrow Transplantation | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cyclosporin A | “Standard immunosuppression treatment includes horse antithymocyte globulin (hATG) and cyclosporin A (CsA).” PMID 38088156 ↗ Dec 2023 |
| Known as | CsA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02099747 ↗ |